Shopping Cart
- Remove All
- Your shopping cart is currently empty
VK-1727, a selective small molecule inhibitor of EBNA1, diminishes the DNA binding activity of EBNA1 and curtails the proliferation and metabolic activity of EBV+ cells while not affecting EBV- cells. This compound is utilized in research pertaining to multiple sclerosis [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $297 | 7-10 days | |
5 mg | $900 | 7-10 days |
Description | VK-1727, a selective small molecule inhibitor of EBNA1, diminishes the DNA binding activity of EBNA1 and curtails the proliferation and metabolic activity of EBV+ cells while not affecting EBV- cells. This compound is utilized in research pertaining to multiple sclerosis [1]. |
In vitro | VK-1727 (25 μM, 72 hours) significantly reduced the total number of G2 cells in EBV+ cells [1]. |
Molecular Weight | 451.51 |
Formula | C29H25NO4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.